iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
2 Adherence Studies- Telaprevir & Boceprevir
  HepDart: Quantification of the Effect of Adherence to Clinical Outcomes in Telaprevir-based Regimens (12/06/11)
EASL: Adherence To Assigned Dosing Regimen and Sustained Virologic Response Among Hepatitis C-Genotype 1 Previously Untreated and Peginterferon/Ribavirin Treatment-Failure Patients Treated With Boceprevir Plus Peginterferon Alfa-2b/Ribavirin (patients with >80% adherence to all dosing achieved 90% cure rates. My guess is if adherence is 100% SVR rates will be higher) - (04/05/11)

  iconpaperstack View Older Articles   Back to Top   www.natap.org